APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pimozide

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Selected research

Industry Growth & Trends

Global Pimozide Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchPimozide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pimozide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pimozide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pimozide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pimozide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.

North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.

Read the full market overview

In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.

Report Scope

This report provides a structured, data-driven view of the global Pimozide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pimozide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pimozide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pimozide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pimozide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pimozide Market by Company

Teva

Par Pharmaceutical

Johnson & Johnson

Eumedica

Pharmascience

Domina Pharmaceuticals

Aa Pharma

Pimozide Segment by Type

1Mg

2Mg

4Mg

Pimozide Segment by Application

Hospitals

Drugstores

Others

Pimozide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pimozide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pimozide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pimozide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pimozide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1Mg Table 2. Major Company of 2Mg Table 3. Major Company of 4Mg Table 4. Global Pimozide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pimozide Sales by Type (2021-2026) & (K Units) Table 6. Global Pimozide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pimozide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pimozide Sales Market Share in Value by Type (2021-2026) Table 9. Global Pimozide Price by Type (2021-2026) & (USD/Unit) Table 10. Global Pimozide Sales by Type (2027-2032) & (K Units) Table 11. Global Pimozide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pimozide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pimozide Sales Market Share in Value by Type (2027-2032) Table 14. Global Pimozide Price by Type (2027-2032) & (USD/Unit) Table 15. North America Pimozide Sales by Type (2021-2026) & (K Units) Table 16. North America Pimozide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pimozide Sales by Type (2021-2026) & (K Units) Table 18. Europe Pimozide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pimozide Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Pimozide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pimozide Sales by Type (2021-2026) & (K Units) Table 22. Latin America Pimozide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pimozide Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Pimozide Sales by Type (2021-2026) & (US$ Million) Table 25. Pimozide Industry Trends Table 26. Pimozide Industry Drivers Table 27. Pimozide Industry Opportunities and Challenges Table 28. Pimozide Industry Restraints Table 29. Global Pimozide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pimozide Revenue Market Share by Company (2021-2026) Table 31. Global Pimozide Sales by Company (2021-2026) & (K Units) Table 32. Global Pimozide Sales Share by Company (2021-2026) Table 33. Global Pimozide Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Pimozide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pimozide Major Company Production Sites and Headquarters Table 36. Global Pimozide Company, Product Type & Application Table 37. Global Pimozide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pimozide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pimozide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pimozide Sales by Region (2021-2026) & (K Units) Table 42. Global Pimozide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pimozide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pimozide Sales Market Share in Value by Region (2021-2026) Table 45. Global Pimozide Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Pimozide Sales by Region (2027-2032) & (K Units) Table 47. Global Pimozide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pimozide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pimozide Sales Market Share in Value by Region (2027-2032) Table 50. Global Pimozide Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Pimozide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pimozide Sales by Application (2021-2026) & (K Units) Table 53. Global Pimozide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pimozide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pimozide Sales Market Share in Value by Application (2021-2026) Table 56. Global Pimozide Price by Application (2021-2026) & (USD/Unit) Table 57. Global Pimozide Sales by Application (2027-2032) & (K Units) Table 58. Global Pimozide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pimozide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pimozide Sales Market Share in Value by Application (2027-2032) Table 61. Global Pimozide Price by Application (2027-2032) & (USD/Unit) Table 62. North America Pimozide Sales by Application (2021-2026) & (K Units) Table 63. North America Pimozide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pimozide Sales by Application (2021-2026) & (K Units) Table 65. Europe Pimozide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pimozide Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Pimozide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pimozide Sales by Application (2021-2026) & (K Units) Table 69. Latin America Pimozide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pimozide Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Pimozide Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Teva Pimozide Product Portfolio Table 76. Teva Recent Development Table 77. Par Pharmaceutical Company Information Table 78. Par Pharmaceutical Business Overview Table 79. Par Pharmaceutical Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Par Pharmaceutical Pimozide Product Portfolio Table 81. Par Pharmaceutical Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Pimozide Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. Eumedica Company Information Table 88. Eumedica Business Overview Table 89. Eumedica Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Eumedica Pimozide Product Portfolio Table 91. Eumedica Recent Development Table 92. Pharmascience Company Information Table 93. Pharmascience Business Overview Table 94. Pharmascience Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Pharmascience Pimozide Product Portfolio Table 96. Pharmascience Recent Development Table 97. Domina Pharmaceuticals Company Information Table 98. Domina Pharmaceuticals Business Overview Table 99. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Domina Pharmaceuticals Pimozide Product Portfolio Table 101. Domina Pharmaceuticals Recent Development Table 102. Aa Pharma Company Information Table 103. Aa Pharma Business Overview Table 104. Aa Pharma Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Aa Pharma Pimozide Product Portfolio Table 106. Aa Pharma Recent Development Table 107. North America Pimozide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Pimozide Sales by Country (2021-2026) & (K Units) Table 109. North America Pimozide Sales Market Share by Country (2021-2026) Table 110. North America Pimozide Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Pimozide Sales Market Share Forecast by Country (2027-2032) Table 112. North America Pimozide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Pimozide Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Pimozide Market Share by Country (2021-2026) Table 115. North America Pimozide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Pimozide Market Share Forecast by Country (2027-2032) Table 117. Europe Pimozide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Pimozide Sales by Country (2021-2026) & (K Units) Table 119. Europe Pimozide Sales Market Share by Country (2021-2026) Table 120. Europe Pimozide Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Pimozide Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Pimozide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Pimozide Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Pimozide Market Share by Country (2021-2026) Table 125. Europe Pimozide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Pimozide Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Pimozide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Pimozide Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Pimozide Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Pimozide Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Pimozide Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Pimozide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Pimozide Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Pimozide Market Share by Country (2021-2026) Table 135. Asia-Pacific Pimozide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Pimozide Market Share Forecast by Country (2027-2032) Table 137. Latin America Pimozide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Pimozide Sales by Country (2021-2026) & (K Units) Table 139. Latin America Pimozide Sales Market Share by Country (2021-2026) Table 140. Latin America Pimozide Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Pimozide Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Pimozide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Pimozide Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Pimozide Market Share by Country (2021-2026) Table 145. Latin America Pimozide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Pimozide Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Pimozide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Pimozide Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Pimozide Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Pimozide Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Pimozide Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Pimozide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Pimozide Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Pimozide Market Share by Country (2021-2026) Table 155. Middle East and Africa Pimozide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Pimozide Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Pimozide Distributors List Table 160. Pimozide Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Pimozide Image Figure 2. Global Pimozide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pimozide Market Size (2021-2032) & (US$ Million) Figure 4. Global Pimozide Sales (2021-2032) & (K Units) Figure 5. 1Mg Image Figure 6. Global 1Mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2Mg Image Figure 8. Global 2Mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 4Mg Image Figure 10. Global 4Mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Pimozide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pimozide Market Share by Type 2025 VS 2032 Figure 13. North America Pimozide Sales Market Share in Volume by Type in 2025 Figure 14. North America Pimozide Sales Market Share in Value by Type in 2025 Figure 15. Europe Pimozide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pimozide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pimozide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pimozide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pimozide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pimozide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pimozide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pimozide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pimozide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Drugstores Image Figure 28. Global Drugstores Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pimozide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pimozide Market Share by Application 2025 VS 2032 Figure 33. North America Pimozide Sales Market Share in Volume by Application in 2025 Figure 34. North America Pimozide Sales Market Share in Value by Application in 2025 Figure 35. Europe Pimozide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pimozide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pimozide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pimozide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pimozide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pimozide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pimozide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pimozide Sales Market Share in Value by Application in 2025 Figure 43. North America Pimozide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pimozide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pimozide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pimozide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pimozide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pimozide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pimozide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pimozide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pimozide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pimozide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pimozide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pimozide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pimozide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pimozide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pimozide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pimozide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pimozide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pimozide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pimozide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pimozide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pimozide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pimozide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1Mg
  • 2Mg
  • 4Mg
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • Teva
  • Par Pharmaceutical
  • Johnson & Johnson
  • Eumedica
  • Pharmascience
  • Domina Pharmaceuticals
  • Aa Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pimozide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pimozide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pimozide Market by Type
  6. 1.3.1 1Mg
  7. 1.3.2 2Mg
  8. 1.3.3 4Mg
  9. 1.4 Global Pimozide Market Size by Type
  10. 1.4.1 Global Pimozide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pimozide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pimozide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pimozide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pimozide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pimozide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pimozide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pimozide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pimozide Industry Trends
  2. 2.2 Pimozide Industry Drivers
  3. 2.3 Pimozide Industry Opportunities and Challenges
  4. 2.4 Pimozide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pimozide Revenue (2021-2026)
  2. 3.2 Global Top Players by Pimozide Sales (2021-2026)
  3. 3.3 Global Top Players by Pimozide Price (2021-2026)
  4. 3.4 Global Pimozide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pimozide Major Company Production Sites & Headquarters
  6. 3.6 Global Pimozide Company, Product Type & Application
  7. 3.7 Global Pimozide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pimozide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pimozide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pimozide Tier 1, Tier 2, and Tier 3
4 Pimozide Regional Status and Outlook
  1. 4.1 Global Pimozide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pimozide Historic Market Size by Region
  3. 4.2.1 Global Pimozide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pimozide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pimozide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pimozide Forecasted Market Size by Region
  7. 4.3.1 Global Pimozide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pimozide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pimozide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pimozide by Application
  1. 5.1 Pimozide Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.1.3 Others
  5. 5.2 Global Pimozide Market Size by Application
  6. 5.2.1 Global Pimozide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pimozide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pimozide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pimozide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pimozide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pimozide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pimozide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pimozide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pimozide Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Par Pharmaceutical
  8. 6.2.1 Par Pharmaceutical Company Information
  9. 6.2.2 Par Pharmaceutical Business Overview
  10. 6.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Par Pharmaceutical Pimozide Product Portfolio
  12. 6.2.5 Par Pharmaceutical Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Pimozide Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Eumedica
  20. 6.4.1 Eumedica Company Information
  21. 6.4.2 Eumedica Business Overview
  22. 6.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eumedica Pimozide Product Portfolio
  24. 6.4.5 Eumedica Recent Developments
  25. 6.5 Pharmascience
  26. 6.5.1 Pharmascience Company Information
  27. 6.5.2 Pharmascience Business Overview
  28. 6.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pharmascience Pimozide Product Portfolio
  30. 6.5.5 Pharmascience Recent Developments
  31. 6.6 Domina Pharmaceuticals
  32. 6.6.1 Domina Pharmaceuticals Company Information
  33. 6.6.2 Domina Pharmaceuticals Business Overview
  34. 6.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
  36. 6.6.5 Domina Pharmaceuticals Recent Developments
  37. 6.7 Aa Pharma
  38. 6.7.1 Aa Pharma Company Information
  39. 6.7.2 Aa Pharma Business Overview
  40. 6.7.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aa Pharma Pimozide Product Portfolio
  42. 6.7.5 Aa Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Pimozide Sales by Country
  2. 7.1.1 North America Pimozide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pimozide Sales by Country (2021-2026)
  4. 7.1.3 North America Pimozide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pimozide Market Size by Country
  6. 7.2.1 North America Pimozide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pimozide Market Size by Country (2021-2026)
  8. 7.2.3 North America Pimozide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pimozide Sales by Country
  2. 8.1.1 Europe Pimozide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pimozide Sales by Country (2021-2026)
  4. 8.1.3 Europe Pimozide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pimozide Market Size by Country
  6. 8.2.1 Europe Pimozide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pimozide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pimozide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pimozide Sales by Country
  2. 9.1.1 Asia-Pacific Pimozide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pimozide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pimozide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pimozide Market Size by Country
  6. 9.2.1 Asia-Pacific Pimozide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pimozide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pimozide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pimozide Sales by Country
  2. 10.1.1 South America Pimozide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pimozide Sales by Country (2021-2026)
  4. 10.1.3 South America Pimozide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pimozide Market Size by Country
  6. 10.2.1 South America Pimozide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pimozide Market Size by Country (2021-2026)
  8. 10.2.3 South America Pimozide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pimozide Sales by Country
  2. 11.1.1 Middle East and Africa Pimozide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pimozide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pimozide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pimozide Market Size by Country
  6. 11.2.1 Middle East and Africa Pimozide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pimozide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pimozide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pimozide Value Chain Analysis
  2. 12.1.1 Pimozide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pimozide Production Mode & Process
  7. 12.2 Pimozide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pimozide Distributors
  10. 12.2.3 Pimozide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst